Gundersen Kjell Gunnar, Gjerdrum Bjørn, Potvin Richard
iFocus Øyeklinikk AS, Haugesund, Norway.
Science in Vision, Bend, OR, USA.
Clin Ophthalmol. 2022 Jul 8;16:2219-2226. doi: 10.2147/OPTH.S372925. eCollection 2022.
To evaluate the visual function of patients with a history of prior laser vision correction and cataract surgery with implantation of a monofocal primary IOL after subsequent implantation of a secondary sulcus trifocal intraocular lens (IOL).
One clinical practice in Haugesund, Norway.
Prospective, single arm, non-interventional unmasked study.
Eligible subjects who had previous laser vision correction and cataract surgery involving implantation of a monofocal IOL in the capsular bag of one or both eyes were subsequently implanted with a secondary IOL in the sulcus. Postoperative uncorrected and best distance-corrected visual acuities (VAs) were measured at distance (4 m), intermediate (60 cm), and near (40 cm), along with low contrast visual acuity and the monocular distance corrected defocus curve.
Twenty-five eyes were evaluated from 7 to 24 months after trifocal implantation. The mean monocular uncorrected VAs were 0.06, 0.21 and 0.10 logMAR at distance, intermediate and near, respectively. Uncorrected near VA was 0.2 logMAR or better in 80% of eyes (20/25). VA of 0.2 logMAR or better at all test distances was achieved in 15/25 eyes (60%) in the uncorrected state and 17/25 eyes (68%) when corrected for distance vision. Binocular uncorrected distance visual acuity was 0.1 logMAR or better in all subjects while binocular uncorrected near visual acuity was 0.1 logMAR or better in all but one subject. The defocus curve showed a range of functional vision from distance to 30 cm. No adverse events were identified.
The trifocal sulcus IOL provided excellent distance and near vision and a good range of functional vision, similar to results obtained when a primary trifocal IOL is implanted. It is a viable option to provide better intermediate and near vision to patients with a prior history of refractive surgery and a monofocal IOL implanted.
评估既往有激光视力矫正和白内障手术史,且在植入单焦点一期人工晶状体(IOL)后又植入二期沟内三焦点人工晶状体(IOL)的患者的视觉功能。
挪威豪格松的一家临床机构。
前瞻性、单臂、非干预性非盲研究。
符合条件的受试者既往有激光视力矫正和白内障手术史,一只或两只眼睛的囊袋内植入了单焦点IOL,随后在沟内植入二期IOL。测量术后在远距离(4米)、中距离(60厘米)和近距离(40厘米)的未矫正和最佳远距离矫正视力(VA),以及低对比度视力和单眼远距离矫正散焦曲线。
在植入三焦点IOL后7至24个月对25只眼进行了评估。单眼未矫正视力在远距离、中距离和近距离的平均对数最小分辨角(logMAR)分别为0.06、0.21和0.10。80%的眼睛(20/25)近距离未矫正视力为0.2 logMAR或更好。在未矫正状态下,15/25只眼(60%)在所有测试距离的视力为0.2 logMAR或更好,在矫正远距离视力时,17/25只眼(68%)达到该水平。所有受试者双眼未矫正远距离视力为0.1 logMAR或更好,除一名受试者外,所有受试者双眼未矫正近距离视力为0.1 logMAR或更好。散焦曲线显示了从远距离到30厘米的一系列功能性视力。未发现不良事件。
三焦点沟内IOL提供了出色的远距离和近距离视力以及良好的功能性视力范围,类似于植入一期三焦点IOL时获得的结果。对于既往有屈光手术史且植入了单焦点IOL的患者,它是提供更好的中距离和近距离视力的可行选择。